Comparative genomics highlights the importance of drug efflux transporters during evolution of mycoparasitism in Clonostachys subgenus Bionectria (Fungi, Ascomycota, Hypocreales)

Martin Broberg; Mukesh Dubey; Mudassir Iqbal; Mikael Gudmundssson; Katarina Ihrmark; Hans-Josef Schroers; Dan Funck Jensen; Mikael Brandström Durling; Magnus Karlsson

doi:10.1111/eva.13134

Comparative genomics highlights the importance of drug efflux transporters during evolution of mycoparasitism in Clonostachys subgenus Bionectria (Fungi, Ascomycota, Hypocreales)

Evol Appl. 2020 Sep 28;14(2):476-497. doi: 10.1111/eva.13134. eCollection 2021 Feb.

Authors

Martin Broberg¹, Mukesh Dubey¹, Mudassir Iqbal¹, Mikael Gudmundssson², Katarina Ihrmark¹, Hans-Josef Schroers³, Dan Funck Jensen¹, Mikael Brandström Durling¹, Magnus Karlsson¹

Affiliations

¹ Department of Forest Mycology and Plant Pathology Swedish University of Agricultural Sciences Uppsala Sweden.
² Department of Molecular Sciences Swedish University of Agricultural Sciences Uppsala Sweden.
³ Agricultural Institute of Slovenia Ljubljana Slovenia.

Abstract

Various strains of the mycoparasitic fungal species Clonostachys rosea are used commercially as biological control agents for the control of fungal plant diseases in agricultural crop production. Further improvements of the use and efficacy of C. rosea in biocontrol require a mechanistic understanding of the factors that determines the outcome of the interaction between C. rosea and plant pathogenic fungi. Here, we determined the genome sequences of 11 Clonostachys strains, representing five species in Clonostachys subgenus Bionectria, and performed a comparative genomic analysis with the aim to identify gene families evolving under selection for gene gains or losses. Several gene families predicted to encode proteins involved in biosynthesis of secondary metabolites, including polyketide synthases, nonribosomal peptide syntethases and cytochrome P450s, evolved under selection for gene gains (p ≤ .05) in the Bionectria subgenus lineage. This was accompanied with gene copy number increases (p ≤ .05) in ATP-binding cassette (ABC) transporters and major facilitator superfamily (MFS) transporters predicted to contribute to drug efflux. Most Clonostachys species were also characterized by high numbers of auxiliary activity (AA) family 9 lytic polysaccharide monooxygenases, AA3 glucose-methanol-choline oxidoreductases and additional carbohydrate-active enzyme gene families with putative activity (or binding) towards xylan and rhamnose/pectin substrates. Particular features of the C. rosea genome included expansions (p ≤ .05) of the ABC-B4 multidrug resistance transporters, the ABC-C5 multidrug resistance-related transporters and the 2.A.1.3 drug:H + antiporter-2 MFS drug resistance transporters. The ABC-G1 pleiotropic drug resistance transporter gene abcG6 in C. rosea was induced (p ≤ .009) by exposure to the antifungal Fusarium mycotoxin zearalenone (1121-fold) and various fungicides. Deletion of abcG6 resulted in mutants with reduced (p < .001) growth rates on media containing the fungicides boscalid, fenhexamid and iprodione. Our results emphasize the role of biosynthesis of, and protection against, secondary metabolites in Clonostachys subgenus Bionectria.

Keywords: Clonostachys; antagonism; biological control; membrane transporter; mycoparasitism; xenobiotics.